Search

Diethyl ether

Insulin peglispro

Psoralen

RO7284755

RO7284755 is under investigation in clinical trial NCT04303858 (A Study to Evaluate Safety and Anti-tumor Activity of RO7284755 Alone or in Combination With Atezolizumab in Participants With Advanced And … RO7284755 is an investigational cancer drug: it is a PD-1-targeted IL-2 variant antibody fusion protein.

CPG 10101

CPG 10101 is a synthetic oligodeoxynucleotide (ODN) in clinical trials.

R1204

R1204 is G-protein-coupled receptor modulator. It is developed for the treatment of depression.

Ulimorelin

Ulimorelin is a novel small molecule ghrelin agonist being developed by Tranzyme Pharma as a first-in-class treatment for both POI and diabetic gastroparesis, serious medical conditions in which motility

MGN-4893

MGN-4893 is an inhibitor of microRNA-451. In February 2011, it was granted FDA orphan designation for the treatment of polycythemia vera.[L47356]

Alcaftadine

This drug was approved in July 2010.

Articaine

Articaine is widely used around the world and is the most popular local anesthetic in many European countries.